A Viewpoint Commentary: Buffalo as a New Model for Long COVID-19 Study and for Recovering the SARS CoV-2 Polyclonal Neutralizing Antibody, Using an Online Affinity Column Adsorption Technology, for Therapeutic Interventional Modality in Humans: A New Multi-Purpose COVID Research Proposal
DOI:
https://doi.org/10.6000/1927-520X.2021.10.07Abstract
.
References
Seghatchian J. Editorial: An introductory commentary on the use of artificial intelligence, machine learning, and TQM as novel computational tools in big data patterns or procedural analysis in transfusion medicine. Transfus Apher Sci 2020; 59: 102985. https://doi.org/10.1016/j.transci.2020.102985 DOI: https://doi.org/10.1016/j.transci.2020.102985
Seghatchian J. New generation of vaccines and convalescent plasma therapy for the management of CoV-2, in the global pandemic. Trans Apher Sci 2021; 103064. https://doi.org/10.1016/j.transci.2021.103064 DOI: https://doi.org/10.1016/j.transci.2021.103064
Seghatchian J. Commentary: Fact and challenges on the global deployment of vaccines for the Immunotherapy of the evolving SARRS CoV-2 variants from the UK perspectives. Trends in Transplant 2021; 14: 1-4. DOI: https://doi.org/10.15761/TiT.1000293
Seghatchian J, Acker JP, Putter JS. Update on newer approaches to prevent or treat COVID-19 infection: what we all need the most right now. Transfus Apher Sci 2020; 102933. https://doi.org/10.1016/j.transci.2020.102933 DOI: https://doi.org/10.1016/j.transci.2020.102933
Seghatchian J, Lanza F. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: Arousing message of clinical benefit to both donors and recipients alike. Transfus Apher Sci 2020; 59(3): 102794. https://doi.org/10.1016/j.transci.2020.102794 DOI: https://doi.org/10.1016/j.transci.2020.102794
Putter JS, Seghatchian J. An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy, and vaccine research. Transfus Apher Sci.
Amiral J, Vissac AM, Seghatchian J. COVID-19, induced activation of hemostasis and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients. Transfus Apher Sci 2020; 59(3): 102804. https://doi.org/10.1016/j.transci.2020.102804 DOI: https://doi.org/10.1016/j.transci.2020.102804
Downloads
Published
How to Cite
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
